Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Supplier dossier · §4

SWB — on-the-record assessments

Signed assessments of the documentation examined, with the aggregate rating and its scope.

Document identifier
CEI-SD-13/4
Series
Supplier dossier
Version
3.0
Published
23 Oct 2025
Last reviewed
23 Jul 2026
Next review
23 Jul 2027
Identifier
10.71829/cei.supp.13
Certainty
Moderate
Cycle
2025 Q4
Assessment score
88.0 / 100
Conformance
A

The Institute assesses documentation, not product. It has purchased nothing, tested nothing and inspected nothing. Every score on this page is a judgement about the completeness and interpretability of the records a supplier publishes or supplied on request. A high score means that a supplier documents its material well. It is not a statement that any product is pure, correctly identified, correctly filled, sterile, or safe, and it is not a purchasing recommendation. The Institute makes no purchasing recommendations.

§4On-the-record assessments

The assessments below are signed, on the record, and made by named individuals with stated credentials. Each concerns the documentation the assessor examined. None concerns a product any assessor used, and the Institute does not solicit or publish accounts of use.

§4.1Aggregate

Modal certainty across assessments
High
Assessments contributing
739
Assessments published in full
26
Scope of the rating
Documentation completeness and interpretability. Not product quality.
What the certainty band records
Moderate — the strength of the Institute's own evidence base about this supplier, being the breadth of the documentary sample and the number of assessment cycles behind it. It is not a quality verdict and nothing on this site presents it as one.
Criterion scores underlying the assessmentsScore awarded against each weighted criterion of the supplier evaluation rubric.Criterion (weight)Score, 0 to 5Certificate-of-analysis completeness25 %4 / 5Independent third-party testing record25 %5 / 5Identity confirmation practice15 %5 / 5Documentation transparency and consistency15 %4 / 5Storage, packaging and cold-chain evidence10 %4 / 5Responsiveness to documented enquiry10 %4 / 5
Figure 3. The six criterion scores. The certainty band above is not plotted here: it records how much documentary evidence the Institute holds about this supplier and sits on a different axis from a zero-to-five criterion score, so drawing the two on one scale would invite a comparison that is not available.

§4.2Published assessments

Dr Viktor Osei, MPharmHigh certainty30 May 2026

The certificate accompanying this consignment satisfies the Institute’s minimum data standard: it carries water content by Karl Fischer in addition to the critical fields. Catalogue availability corresponded to the published catalogue.

Dr Julia Lehtinen, PharmDHigh certainty18 Mar 2026

Fill uniformity was assessed by weighing 3 units from a single consignment against declared fill. All units fell within two per cent of the declared mass. The supplementary certificate was retrieved without demur. The finding covers the lots named and is not generalised beyond them.

Dr Ferran Szabo, MDHigh certainty15 Jan 2026

The certificate accompanying the consignment was the lot-specific document rather than a batch-level one, and its lot number corresponded to the number printed on the vial. Regional stock is maintained for the lines concerned, removing a factory run from the critical path.

Dr Ravi Guerrero, PhD (Medicinal Chemistry)High certainty01 Jul 2026

Packing was assessed as adequate to the transit undertaken: the desiccant sachet actually inside the secondary container. No excipient was present and the lyophilised cake was intact.

Dr Rosa Delgado, MSc (Analytical Science)High certainty25 May 2026

The storage condition against which the stability statement was written is stated on the certificate, which permits the statement to be evaluated rather than merely noted. The desiccant sachet was enclosed within the secondary container. The submission is recorded in full in the evidence log.

Dr Dario Falk, MD, MPHHigh certainty10 Mar 2026

Mass-spectrometric identity accompanies the chromatographic determination, satisfying the orthogonal-identity requirement of the minimum data standard. A signature and release date appear on the certificate. The assessor declares no interest in the supplier beyond the transactions described.

Dr Jonas Villalobos, PhD (Biochemistry)High certainty28 Jan 2026

The declared figure was not adjusted upward between the certificate and the commercial documentation. Discrepancies of this kind are specifically screened for. Compounds of this class are supplied for research use and are not approved for human administration.

Dr Chiara Steiner, MRPharmSHigh certainty03 Mar 2025

Material from lot SWB-24-793 was submitted to Janoshik; the determination returned 99.3% against a declared 98.9%, a difference within the stated repeatability of the method. The supplementary certificate was retrieved without demur.

Dr Tomas Onwuka, PhD (Analytical Chemistry)High certainty16 Jun 2026

Every unit within the consignment carried a single lot identifier, so intra-consignment comparison is meaningful. Identity was confirmed by two orthogonal methods. Nothing in this submission constitutes medical advice.

Dr Bianca Novak, PhD (Pharmaceutical Sciences)High certainty25 Jan 2026

Purity is declared by a stability-indicating chromatographic method, and the method, column chemistry and detection wavelength are all named on the certificate. The declaration is therefore assessable. The reorder placed at 12 months returned a figure within one tenth of a point of the original. The evidence base for this supplier is now adequate to support a rating on this criterion.

Dr Rosa Vogel, MPharmHigh certainty26 Jan 2026

Cold-chain integrity was maintained through transit; the phase-change pack remained solid to arrival on day 6. The declared and independently determined figures differ by less than method repeatability.

Dr Mikkel Solberg, PharmDHigh certainty21 Nov 2025

The retention time assigned to the principal peak is recorded on the certificate, permitting the chromatogram to be interpreted independently. A signature and release date appear on the certificate. Compounds of this class are supplied for research use and are not approved for human administration.

Dr Sanne Broberg, MDHigh certainty22 Jun 2026

Material for this line was held in regional stock and reached the purchaser without a factory run entering the critical path. Catalogue availability corresponded to the published catalogue.

Dr Mariam Moreau, PhD (Medicinal Chemistry)High certainty14 Feb 2026

Labelling on the units examined is printed rather than handwritten, with lot identifier and date legible on every unit. The gradient and column chemistry are stated, permitting the determination to be reproduced. The assessor has placed subsequent orders with the same supplier.

Dr Tove Novak, MSc (Analytical Science)High certainty08 Apr 2026

The order acknowledgement stated the dispatching warehouse, which allows the transit history of the lot to be reconstructed. Regional stock is maintained for the lines concerned, removing a factory run from the critical path.

Dr Aisha Fonseca, MD, MPHHigh certainty05 May 2026

Water content is reported by Karl Fischer titration with the determination method named, which the rubric requires and which a minority of suppliers provide. The finding covers the lots named and is not generalised beyond them.

Dr Milos Mwangi, PhD (Biochemistry)High certainty15 Jan 2025

Batch traceability is complete: the identifier on the primary container corresponds to that on the certificate and to that on the commercial documentation. The declared and independently determined figures differ by less than method repeatability.

Dr Yara Guerrero, MRPharmSHigh certainty15 Mar 2026

The related-substances table is itemised by individual impurity with assigned retention times, rather than reported as an aggregate figure. The VendorInvestigate report is held on file and corresponds to the figures published by the supplier. Nothing in this submission constitutes medical advice.

Dr Saskia Nyberg, PhD (Analytical Chemistry)High certainty07 Jan 2026

Every vial in the consignment carried a legible lot code matching the accompanying paperwork. They switched to a phase-change pack for the reorder without being asked and it arrived hard, and documentation for lot SWB-26-171 was complete at first issue. Catalogue availability corresponded to the published catalogue.

Dr Dagny Zielinski, PhD (Pharmaceutical Sciences)High certainty24 Apr 2025

A custom-synthesis engagement was completed 2 days inside the quoted schedule, at the purity specified in the signed specification. The supplementary certificate was retrieved without demur.

Dr Fatima Salinas, MPharmHigh certainty18 Mar 2026

Independent determinations obtained from Medutest and from PeptideMeter on the same lot agree to within one tenth of a percentage point, and both agree with the declared figure. Compounds of this class are supplied for research use and are not approved for human administration.

Dr Elodie Bhattacharya, PharmDHigh certainty25 Feb 2026

A supplementary certificate covering a lot released 18 months previously was produced from the supplier’s records on request, indicating that release records are retained rather than reconstructed. No excipient was present and the lyophilised cake was intact. This is a single assessor’s record and carries the weight the rubric assigns to one.

Dr Liv Kaufmann, MDHigh certainty25 Mar 2026

This assessor has placed 4 orders across 12 months and holds documentation for each. The set is internally consistent. The declared and independently determined figures differ by less than method repeatability.

Dr Yusuf Broberg, PhD (Medicinal Chemistry)High certainty14 Dec 2025

A repeat determination on the same catalogue line at 8 months returned 98.0%, against 98.0% originally. No evidence of process drift is present in this sample. The Janoshik report is held on file and corresponds to the figures published by the supplier. Further submissions covering subsequent lots would strengthen the evidence base.

Dr Aisha Bakken, MSc (Analytical Science)High certainty21 May 2025

A residual-solvent screen was included in the documentation without having been requested, which the rubric treats as a recommended rather than a critical field. Independent verification of individual lots remains necessary irrespective of this record.

Dr Fabio Vasquez, MD, MPHHigh certainty10 May 2025

Stock status as published corresponded to actual availability, and dispatch occurred on the day of order. No adverse finding arises from the transactions described.

§4.3The supplier’s own account

Each assessment above concerns a document the assessor examined. None of them concerns what SWB says about itself, which is published at its own address and is worth reading beside them rather than instead of them.

Read SWB’s own account at shanghaiwibsonbiotechnology.net →

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.